White powder ;
Assay:>98%
For the treatment of advanced breast cancer
Entenol is a novel oral HDAC1 inhibitor, which is different from other HDAC inhibitors in terms of safety and efficacy, whether as a single drug or in combination with existing commercially available targeted therapeutic drugs.